Polymeric system for dual growth factor delivery

被引:1347
作者
Richardson, TP
Peters, MC
Ennett, AB
Mooney, DJ [1 ]
机构
[1] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA
关键词
D O I
10.1038/nbt1101-1029
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The development of tissues and organs is typically driven by the action of a number of growth factors. However, efforts to regenerate tissues (e.g., bone, blood vessels) typically rely on the delivery of single factors, and this may partially explain the limited clinical utility of many current approaches. One constraint on delivering appropriate combinations of factors is a lack of delivery vehicles that allow for a localized and controlled delivery of more than a single factor. We report a new polymeric system that allows for the tissue-specific delivery of two or more growth factors, with controlled dose and rate of delivery. The utility of this system was investigated in the context of therapeutic angiogenesis. We now demonstrate that dual delivery of vascular endothelial growth factor (VEGF)-165 and platelet-derived growth factor (PDGF)-BB, each with distinct kinetics, from a single, structural polymer scaffold results in the rapid formation of a mature vascular network. This is the first report of a vehicle capable of delivery of multiple angiogenic factors with distinct kinetics, and these results clearly indicate the importance of multiple growth factor action in tissue regeneration and engineering.
引用
收藏
页码:1029 / 1034
页数:6
相关论文
共 33 条
  • [1] Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
    Baumgartner, I
    Pieczek, A
    Manor, O
    Blair, R
    Kearney, M
    Walsh, K
    Isner, JM
    [J]. CIRCULATION, 1998, 97 (12) : 1114 - 1123
  • [2] Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
    Benjamin, LE
    Golijanin, D
    Itin, A
    Pode, D
    Keshet, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) : 159 - 165
  • [3] Benjamin LE, 1998, DEVELOPMENT, V125, P1591
  • [4] Mechanisms of angiogenesis and arteriogenesis
    Carmeliet, P
    [J]. NATURE MEDICINE, 2000, 6 (04) : 389 - 395
  • [5] CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES
    COHEN, S
    YOSHIOKA, T
    LUCARELLI, M
    HWANG, LH
    LANGER, R
    [J]. PHARMACEUTICAL RESEARCH, 1991, 8 (06) : 713 - 720
  • [6] Blood vessel maturation: Vascular development comes of age
    Darland, DC
    D'Amore, PA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) : 157 - 158
  • [7] CONTROLLED AND MODULATED RELEASE OF BASIC FIBROBLAST GROWTH-FACTOR
    EDELMAN, ER
    MATHIOWITZ, E
    LANGER, R
    KLAGSBRUN, M
    [J]. BIOMATERIALS, 1991, 12 (07) : 619 - 626
  • [8] Blood vessel formation: What is its molecular basis?
    Folkman, J
    DAmore, PA
    [J]. CELL, 1996, 87 (07) : 1153 - 1155
  • [9] BIODEGRADABLE POLYMERS FOR PROTEIN AND PEPTIDE DRUG-DELIVERY
    GOMBOTZ, WR
    PETTIT, DK
    [J]. BIOCONJUGATE CHEMISTRY, 1995, 6 (04) : 332 - 351
  • [10] Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion - Evidence for a dose-dependent effect
    Hendel, RC
    Henry, TD
    Rocha-Singh, K
    Isner, JM
    Kereiakes, DJ
    Giordano, FJ
    Simons, M
    Bonow, RO
    [J]. CIRCULATION, 2000, 101 (02) : 118 - 121